Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$20.0 - $25.48 $1.03 Million - $1.31 Million
-51,600 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$11.4 - $18.36 $12,540 - $20,196
-1,100 Reduced 2.09%
51,600 $905,000
Q3 2020

Nov 05, 2020

SELL
$10.57 - $16.0 $35,885 - $54,320
-3,395 Reduced 6.05%
52,700 $632,000
Q2 2020

Aug 12, 2020

BUY
$10.5 - $17.36 $468,867 - $775,193
44,654 Added 390.3%
56,095 $903,000
Q4 2019

Jan 27, 2020

BUY
$14.08 - $18.5 $20,289 - $26,658
1,441 Added 14.41%
11,441 $161,000
Q2 2018

Aug 15, 2018

BUY
$16.77 - $22.76 $167,700 - $227,600
10,000 New
10,000 $228,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.88B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.